A list of all articles and press releases in the IJN Media Centre that are associated with the keyword: InnovatorDrugsAlternatifGenerik.
MOPI says shifting to generics and biosimilars, which are widely used in developed countries, will ensure IJN’s sustainability. “Generics and biosimilars are not ‘cheap alternatives’...